Bridging the gap between biologic, individual, and macroenvironmental factors in cancer: A multilevel approach

Cancer Epidemiology Biomarkers and Prevention

Volumn 22, Issue 4, 2013, Pages 485-495

  Lynch, Shannon M ^a   Rebbeck, Timothy R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS; BIOLOGICAL FACTOR; BIOLOGICAL MARKER; BRCA1 PROTEIN; BRCA2 PROTEIN; PROSTATE SPECIFIC ANTIGEN; RADON;

ARTICLE; BEHAVIOR; BEHAVIOR CHANGE; BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CHROMOSOMAL INSTABILITY; CHROMOSOME DAMAGE; CONCEPTUAL FRAMEWORK; DIET; DNA ADDUCT; DNA REPLICATION; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; FAMILY; FAMILY RELATION; GENE INTERACTION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HEALTH CARE POLICY; HEALTH CARE SYSTEM; MOLECULAR BIOLOGY; MOLECULAR EPIDEMIOLOGY; NEIGHBORHOOD; OVARY CANCER; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSTATE CANCER; PSYCHOLOGICAL ASPECT; SMOKING; SMOKING CESSATION; SOCIAL ASPECT; SOCIAL INTERACTION; SOCIAL STATUS; SOCIAL SUPPORT; SOCIOECONOMICS; SOMATIC MUTATION; SPONTANEOUS MUTATION; STUDY DESIGN; TOBACCO DEPENDENCE; TUMOR MICROENVIRONMENT;

BIOLOGICAL AGENTS; GENETIC PREDISPOSITION TO DISEASE; HEALTH POLICY; HUMANS; NEOPLASMS; RISK FACTORS; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 84876543915     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-13-0010     Document Type: Article

References (87)

1. Krieger N. Defining and investigating social disparities in cancer: critical issues. Cancer Causes Control 2005;16:5-14. (Pubitemid 40568846)
2. Krieger N, Quesenberry C, Peng T, Horn-Ross P, Stewart S, Brown S, et al. Social class, race/ethnicity, and incidence of breast, cervix, colon, lung, and prostate cancer among Asian, black, Hispanic, and white residents of the San Francisco Bay Area, 1988-92 (United States). Cancer Causes Control 1999;10:525-37.
3. Hiatt RA, Breen N. The social determinants of cancer: a challenge for transdisciplinary science. Am J Prev Med 2008;35:S141-50. (Pubitemid 351932071)
4. Holmes JH, Lehman A, Hade E, Ferketich AK, Gehlert S, Rauscher GH, et al. Challenges for multilevel health disparities research in a transdisciplinary environment. Am J Prev Med 2008;35:S182-92. (Pubitemid 351932082)
5. National Cancer Institute and National Institutes of Environmental Health Sciences. Cancer and the Environment. National Institutes of Health. Bethesda, MD; 2003.
6. Aarts MJ, Lemmens VEPP, Louwman MWJ, Kunst AE, Coebergh JWW. Socioeconomic status and changing inequalities in colorectal cancer? A review of the associations with risk, treatment and outcome. Eur J Cancer 2010;46:2681-95.
7. Bradley CJ, Given CW, Roberts C. Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst 2002; 94:490-6. (Pubitemid 34411287)
8. Dayal HH, Polissar L, Dahlberg S. Race, socioeconomic status, and other prognostic factors for survival from prostate cancer. J Natl Cancer Inst 1985;74:1001-6. (Pubitemid 15062957)
9. The United States Department of Health and Human Services. The health consequences of smoking: A Report of the Surgeon General. Washington, D.C., 2004.
10. Lubin JH. Environmental Factors in Cancer: Radon. Rev Environ Health 2010;25:33-38.
11. Orenstein MR, Schenker MB. Environmental asbestos exposure and mesothelioma. Curr Opin Pulm Med 2000;6:371-7. (Pubitemid 30469240)
12. Gibson TM, Ferrucci LM, Tangrea JA, Schatzkin A. Epidemiological and clinical studies of nutrition. Semin Oncol 2010;37:282-96.
13. Na H-K, Oliynyk S. Effects of physical activity on cancer prevention. Ann N Y Acad Sci 2011;1229:176-83.
14. Varghese JS, Easton DF. Genome-wide association studies in common cancers-what have we learnt? Curr Opin Genet Dev 2010;20: 201-9.
15. Hecht SS. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 1999;91:1194-210. (Pubitemid 29357186)
16. Thun MJ, Henley SJ, Burns D, Jemal A, Shanks TG, Calle EE. Lung cancer death rates in lifelong nonsmokers. J Natl Cancer Inst 2006; 98:691-9. (Pubitemid 43832505)
17. Rebbeck TR, Kauff ND, Domchek SM. Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst 2009;101:80-7.
18. Plewis I. Statistics in education. London: Edward Arnold; 1997.
19. MacMahon B, Pugh TF, editors. Epidemiology: principles and methods. Boston, MA: Little, Brown and Company, 1970.
20. Mausner J, Kramer S, Bahn. Epidemiology: An Introductory Texts, Saunders, Philadelphia, PA; 1985.
21. Galea S, Riddle M, Kaplan GA. Causal thinking and complex system approaches in epidemiology. Int J Epidemiol 2010;39:97-106.
22. Warnecke RB, Oh A, Breen N, Gehlert S, Paskett E, Tucker KL, et al. Approaching health disparities from a population perspective: the National Institutes of Health Centers for Population Health and Health Disparities. Am J Public Health 2008;98:1608-15.
23. Taplin SH, Anhang Price R, Edwards HM, Foster MK, Breslau ES, Chollette V, et al. Introduction: understanding and influencing multilevel factors across the cancer care continuum. J Natl Cancer Inst Monogr 2012;2012:2-10.
24. Gorin SS, Badr H, Krebs P, Das IP. Multilevel interventions and racial/ethnic health disparities. J Natl Cancer Inst Monogr 2012;2012: 100-11.
25. Glass TA, McAtee MJ. Behavioral science at the crossroads in public health: extending horizons, envisioning the future. Soc Sci Med 2006;62:1650-71. (Pubitemid 43243264)
26. Caporaso NE. Integrative study designs-next step in the evolution of molecular epidemiology? Cancer Epidemiol Biomarkers Prev 2007; 16:365-6. (Pubitemid 46548631)
27. Spitz MR, Caporaso NE, Sellers TA. Integrative cancer epidemiology- the next generation. Cancer Discov 2012;2:1087-90.
28. Rappaport SM. Implications of the exposome for exposure science. J Expos Sci Environ Epidemiol 2011;21:5-9.
29. Gelfand LA, Mensinger JL, Tenhave T. Mediation analysis: a retrospective snapshot of practice and more recent directions. J Gen Psychol 2009;136:153-76.
30. Hox JJ. Applied multilevel analysis. Amsterdam, the Netherlands: TTPublikaties; 1994.
31. Kreft I, De Leeuw J. Introducing multilevel modelling. London: Sage; 1998.
32. Raudenbush SW, Willms JDE. Schools, classrooms and pupils. San Diego, CA: Academic Press; 1991.
33. Morrissey JP, Lich KH, Price RA, Mandelblatt J. Computational modeling and multilevel cancer control interventions. J Natl Cancer Inst Monogr 2012;2012:56-66.
34. Office of Behavioral and Social Sciences Research, National Institutes of Health (NIH). Toward higher levels of analysis: progress and promise in research on social and cultural dimensions of health. NIH: Bethesda, MD; 2000.
35. Lam TK, Spitz M, Schully SD, Khoury MJ. Drivers of translational cancer epidemiology in the 21st century: needs and opportunities. Cancer Epidemiol Biomarkers Prev 2013;22:181-8.
36. Khoury MJ, Gwinn M, Yoon PW, Dowling N, Moore CA, Bradley L. The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? Genet Med 2007;9:665-74. (Pubitemid 350287151)
37. Khoury MJ, Gwinn M, Bowen MS, Dotson WD. Beyond base pairs to bedside: a population perspective on how genomics can improve health. Am J Public Health 2011;102:34-7.
38. Siemiatycki J, Thomas DC. Biological models and statistical interactions: an example from multistage carcinogenesis. Int J Epidemiol 1981;10:383-7. (Pubitemid 12164642)
39. Thompson WD. Effect modification and the limits of biological inference from epidemiologic data. J Clin Epidemiol 1991;44:221-32.
40. Cortessis V,Thomas DC. Toxicokinetic genetics: an approach to geneenvironment and gene-gene interactions in complex metabolic pathways. IARC Sci Publ 2004:127-50.
41. Perera FP, Schulte, PA. Chapter 1: A Conceptual and Historical Framework for Molecular Epidemiology. Molecular epidemiology: principles and practices. In: Schulte PA, Perera FP, editors. San Diego, CA: Academic Press; 1993.
42. Perera F, Weinstein IB. Molecular epidemiology and carcinogen-DNA adduct detection: new approaches to studies of human cancer causation. J Chronic Dis 1982;35:581-600. (Pubitemid 12085585)
43. Guy M, Kote-Jarai Z, Giles GG, Al Olama AA, Jugurnauth SK, Mulholland S, et al. Identification of new genetic risk variants for prostate cancer. Asian J Androl 2009;11:49-55.
44. Perera F. Molecular cancer epidemiology: a new tool in cancer prevention. J Natl Cancer Inst 1987;78:887-98. (Pubitemid 17093013)
45. Schulte PA, Rothman N, Schottenfeld D. Chapter 6: Design Considerations in Molecular Epidemiology. Molecular epidemiology: principles and practices. In: Schulte PA, Perera FP, editors. San Diego, CA: Academic Press; 1993.
46. Patel CJ, Bhattacharya J, Butte AJ. An environment-wide association study (EWAS) on type 2 diabetes mellitus. PLoS ONE 2010;5:e10746.
47. Thomas DC, Siemiatycki J, Dewar R, Robins J, Goldberg M, Armstrong BG. The problem of multiple inference in studies designed to generate hypotheses. Am J Epidemiol 1985;122:1080-95. (Pubitemid 16170043)
48. Ioannidis JP, Loy EY, Poulton R, Chia KS. Researching genetic versus nongenetic determinants of disease: a comparison and proposed unification. Sci Transl Med 2009;1:7ps8.
49. Swartz MA, Iida N, Roberts EW, Sangaletti S, Wong MH, Yull FE, et al. Tumor microenvironment complexity: emerging roles in cancer therapy. Cancer Res 2012;72:2473-80.
50. Tainsky MA. Genomic and proteomic biomarkers for cancer: a multitude of opportunities. Biochim Biophys Acta 2009;1796:176-93.
51. Dove A. Proteomics: translating genomics into products. Nat Biotechnol 1999;17:233-6.
52. Meltzer PS. Cancer genomics: small RNAs with big impacts. Nature 2005;435:745-6. (Pubitemid 40839710)
53. Andriole GL, Crawford ED, Grubb RL, Buys SS, Chia D, Church TR, et al. Prostate cancer screening in the randomized prostate, lung, colorectal, and ovarian cancer screening trial: mortality results after 13 years of follow-up. J Natl Cancer Inst 2012;104:125-32.
54. Spratlin JL, Serkova NJ, Eckhardt SG. Clinical applications of metabolomics in oncology: a review. Clin Cancer Res 2009;15:431-40.
55. McDermott U, Downing JR, Stratton MR. Genomics and the continuum of cancer care. N Engl J Med 2011;364:340-50.
56. Foulkes WD. Inherited susceptibility to common cancers.NEngl JMed 2008;359:2143-53.
57. Manolio TA. Genome-wide association studies and disease risk assessment. N Engl J Med 2010;363:166-76.
58. Chen G, Wei P, DeStefano AL. Incorporating biological information into association studies of sequencing data. Genet Epidemiol 2011;35: S29-S34.
59. Cordell HJ. Epistasis: what it means, what it doesn't mean, and statistical methods to detect it in humans. Hum Mol Genet 2002;11: 2463-8. (Pubitemid 35174710)
60. Fehringer G, Liu G, Briollais L, Brennan P, Amos CI, Spitz MR, et al. Comparison of pathway analysis approaches using lung cancerGWAS data sets. PLoS ONE 2012;7:e31816.
61. Weiner BJ, Lewis MA, Clauser SB, Stitzenberg KB. In search of synergy: strategies for combining interventions at multiple levels. J Natl Cancer Inst Monogr 2012;2012:34-41.
62. Stokols D. Establishing and maintaining healthy environments: toward a social ecology of health promotion. Am Psychol 1992;47:6-22.
63. Stokols D. Translating social ecological theory into guidelines for community health promotion. Am J Health Promot 1996;10:282-98. (Pubitemid 26081505)
64. Lobo I. Same genetic mutation, different genetic disease phenotype. Nat Educ 2008;1(1). Available from: http://www.nature.com/scitable/topicpage/same- genetic-mutation-different-genetic-disease-phenotype- 938 [accessed November 30, 2012].
65. Cornelis MC, Tchetgen EJ, Liang L, Qi L, Chatterjee N, Hu FB, et al. Gene-environment interactions in genome-wide association studies: a comparative study of tests applied to empirical studies of type 2 diabetes. Am J Epidemiol 2012;175:191-202.
66. Yano EM, Green LW, Glanz K, Ayanian JZ, Mittman BS, Chollette V, et al. Implementation and spread of interventions into the multilevel context of routine practice and policy: implications for the cancer care continuum. J Natl Cancer Inst Monogr 2012;2012:86-99.
67. American Cancer Society. Cancer facts and figures 2010 tables and figures; 2010. http://www.cancer.org/research/cancerfactsfigures/ cancerfactsfigures/most-requested-tables-figures-2010. [cited 2011; retrieved 2011 Apr 19].
68. Lansdorp PM. Stress, social rank, and leukocyte telomere length. Aging Cell 2006;5:583-4. (Pubitemid 44782630)
69. Crawford ED. Epidemiology of prostate cancer. Urology 2003;62:3-12. (Pubitemid 38050194)
70. De Angelis G, Rittenhouse HG, Mikolajczyk SD, Blair Shamel L, Semjonow A. Twenty years of PSA: from prostate antigen to tumor marker. Rev Urol 2007;9:113-23.
71. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 1987;317:909-16. (Pubitemid 17147932)
72. Catalona WJ, Smith DS, Ratliff TL, Dodds KM, Coplen DE, Yuan JJ, et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 1991;324:1156-61.
73. Catalona W, Hudson MA, Scardino PT, Richie JP, Ahmann FR, Flanigan RC, et al. Selection of optimal prostate specific antigen cutoffs for early dection of prostate cancer: receiver operating characteristic curves. J Urol 1994;152:2037-42. (Pubitemid 24354722)
74. United States Preventive Task Force. Screening for prostate cancer; 2012. Available from: http://www.uspreventiveservicestaskforce.org/ prostatecancerscreening.htm. [accessed December 1, 2012]
75. American Cancer Society. Guidelines for the early detection of cancer (prostate cancer). In American Cancer Society. Atlanta, Georgia, 2012.
76. National Comprehensive Cancer Network (NCCN). Prostate cancer early detection guidelines, version 2. NCCN Clinical Practice Guidelines in Oncology; Fort Washington, PA. 2007.
77. Vickers AJ, Roobol MJ, Lilja H. Screening for prostate cancer: early detection or overdetection? Annu Rev Med 2012;63:161-70.
78. Schroder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 2009;360:1320-8.
79. Andriole GL, Grubb RL III, Buys SS, Chia D, Church TR, Fouad MN, et al. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 2009;360:1310-9.
80. Zeigler-Johnson C, Tierney A, Rebbeck TR, Rundle A. Prostate cancer severity associations with neighborhood deprivation. Prostate Cancer 2011;2011:PMID 22111000.
81. Subramanian SV, Kubzansky L, Berkman L, Fay M, Kawachi I. Neighborhood effects on the self-rated health of elders: uncovering the relative importance of structural and service-related neighborhood environments. J Gerontol B 2006;61:S153-60. (Pubitemid 43726362)
82. Fowke JH, Schlundt D, Signorello LB, Ukoli FA, Blot WJ. Prostate cancer screening between low-income African-American and Caucasian Men. Urol Oncol 2005;23:333-40. (Pubitemid 41247848)
83. Berglund A, Garmo H, Robinson D, Tishelman C, Holmberg L, Bratt O, et al. Differences according to socioeconomic status in the management and mortality in men with high risk prostate cancer. Eur J Cancer 2012;48:75-84.
84. Carpenter W, Howard D, Taylor Y, Ross L, Wobker S, Godley P. Racial differences in PSA screening interval and stage at diagnosis. Cancer Causes Control 2010;21:1071-80.
85. Xiao H, Gwede CK, Kiros G, Milla K. Analysis of prostate cancer incidence using geographic information system and multilevel modeling. J Natl Med Assoc 2007;99:218-25. (Pubitemid 46399379)
86. Rundle A, Richards C, Neslund-Dudas C, Tang D, Rybicki BA. Neighborhood socioeconomic status modifies the association between individual smoking status and PAH-DNA adduct levels in prostate tissue. Environ Mol Mutagen 2012;53:384-91.
87. Rebbeck TR, Weber AL, Walker AH, Stefflova K, Tran TV, Spangler E, et al. Context-dependent effects of genome-wide association study genotypes and macroenvironment on time to biochemical (prostate specific antigen) failure after prostatectomy. Cancer Epidemiol Biomarkers Prev 2010;19:2115-23.